Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 May 15;10:8060. doi: 10.1038/s41598-020-64950-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Identification of MEGF11 in recurrent triple negative breast cancer. Using cDNA open array chips, 224 genes in paired TNBC tissue samples (16 recurrent and 24 non-recurrent tissues) were analysed, and MEGF11 was significantly upregulated in tumour tissues with subsequent clinical recurrence compared with those without recurrence (a). Protein expression by immunohistochemistry (b) was correlated with patient survival, including recurrence-free survival (c) and overall survival (d). The protein expression of MEGF11 was semi-quantified and expressed as (0), <10%, (1), 11–25%, (2), 26–50%, and (3)>50% of tumour cells. The MEGF11 expression level was defined as low (≤25%, n = 87) and high (> 25%, n = 48). Data are presented as the mean ± SD. Asterisks indicate a p value <0.05 by Mann-Whitney U test, and Kaplan-Meier survival analysis was performed with Prism 5 software.